Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Must Reads In Cardiology

Cardiology for May/June 2016

Hypertensive Urgency in an Outpatient Setting, JAMA Intern Med; ePub 2016 Jun 13; Patel, Young, et al

Liraglutide & CV Outcomes in Patients with T2D, N Engl J Med; ePub 2016 Jun 13; Marso, Daniels, et al

Can Empagliflozin Slow Progression of Kidney Disease?, N Engl J Med; ePub 2016 Jun 14; Wanner, Inzucchi, et al

BP Target in Patients with Acute Cerebral Hemorrhage, N Engl J Med; ePub 2016 Jun 8; Qureshi, Palesch, et al

FDA Approves Combo Drug for Treatment of Hypertension, Allergan news release; 2016 Jun 6

More must reads

Cardiology for March/April 2016

Aspirin Use Guidelines for Prevention of CV & CRC, Ann Intern Med; ePub 2016 Apr 12; Bibbins-Domingo, et al

Knowledge Gaps in Cardiovascular Care of Older Adults, Circulation; ePub 2016 Apr 11; Rich, Chyun, et al

BMI in Adolescence & CV Death in Adulthood, N Engl J Med; ePub 2016 Apr 13; Twig, Yaniv, et al

Cholesterol Lowering in Intermediate-Risk Persons, N Engl J Med; ePub 2016 Apr 2; Yusuf, Bosch, et al

More must reads

Cardiology for January/February 2016

Normal-Weight Central Obesity & Mortality Risk, Evaluating older adults with CAD

Remote Monitoring of Patients with Heart Failure, Effectiveness after discharge studied

Acute Myocardial Infarction in Women, AHA statement examines sex-specific differences

Antithrombotic Therapy for VTE Disease, Updated guidelines for VTE treatment

More must reads

Cardiology for November/December 2015

Cholesterol Treatment Eligibility & Medication Use, Prevalence among US adults examined

Normal-Weight Central Obesity & Mortality, How it compares to BMI-defined obesity

Cardiorespiratory Fitness and Obesity, Identifying men at increased mortality risk

Coffee Consumption and Risk of Mortality, How many cups are too many?

Walnut Ingestion and Diet Quality, Effects on body composition, cardiac risk studied

More must reads

Cardiology for September/October 2015

Screening for High Blood Pressure, USPSTF updates guidelines

Insulin Dose and Cardiovascular Mortality, Does intensive T2D treatment heighten CV risk?

FDA Approves Praxbind as Reversal Agent, Drug reverses effects of dabigatran

Physical Activity and Heart Failure Risk, Examining the dose response relationship

Cardiac Troponin in Patients with ACS, Can hospital admissions be reduced?

More must reads